Resources Contact Us Home
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies

Image Number 12 for United States Patent #7491393.

The present invention relates to the identification of antibodies which are specific to human B7.1 antigen (CD80) and which are capable of inhibiting the binding of B7.1 to a CD28 receptor and which are not capable of inhibiting the binding of B7.1 to a CTLA-4 receptor. Two of these antibodies, 16C10 and 7C10, significantly inhibit the production of IL-2, in spite of the existence of a second activating ligand B7.2 (CD86). Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 and/or B7.2 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signalling. These antibodies may be used as specific immunosuppressants, e.g., for the treatment of autoimmune diseases and to prevent organ transplant rejection.

  Recently Added Patents
Communication apparatus and communication system
Transactional consistency scheme
Opioid-nornicotine codrugs combinations for pain management
Passive millimeter wave differential interference contrast polarimetry
Semiconductor memory device and manufacturing method thereof
Self-service administration of a database
Human activity monitoring device
  Randomly Featured Patents
3D vertical NAND and method of making thereof by front and back side processing
Composition of amorphous iron oxide hydroxide, desulfurizer comprising the same, and methods for preparing and regenerating the desulfurizer
Computer user interface with head motion input
Apparatus for manufacturing dual in-line packages
Electric junction box
Apparatus for drying shoes in a dryer
Counter balanced, hands free, self positioning, protective shield
Multicolor ink transfer arrangement and method
Process and apparatus for the formation of fiber felts
Method for producing crystalline silicon